Login / Signup

Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force.

Kamilla Woznica MiskowiakIda SeebergMette B JensenVicent Balanzá-MartínezCaterina Del Mar BonninChristopher R BowieAndre Fèrrer CarvalhoAnnemieke DolsKatie M DouglasPeter GallagherGregor HaslerBeny LaferKathryn E LewandowskiCarlos López-JaramilloAnabel Martinez-AranRoger S McIntyreRichard A BryantScot E PurdonAyal SchafferPaul R A StokesTomiki SumiyoshiIvan J TorresTamsyn E Van RheenenLakshmi N YathamAllan H YoungLars Vedel KessingKatherine E BurdickEduard Vieta
Published in: Bipolar disorders (2022)
Evidence for pro-cognitive treatments in mood disorders is emerging. Recommendations are to increase sample sizes, pre-screen for impairment in targeted domain(s), select one primary outcome, aid transfer to real-world functioning, investigate multimodal interventions and include neuroimaging.
Keyphrases
  • bipolar disorder
  • cancer therapy
  • mild cognitive impairment
  • physical activity
  • sleep quality
  • high throughput
  • randomized controlled trial
  • pain management
  • clinical trial
  • clinical practice
  • systematic review